-
Something wrong with this record ?
Allergy-like immediate reactions with herbal medicines in children: A retrospective study using data from VigiBase®
R. Meincke, J. Pokladnikova, J. Straznicka, RHB. Meyboom, D. Niedrig, S. Russmann, L. Jahodar,
Language English Country England, Great Britain
Document type Journal Article, Multicenter Study
PubMed
28846157
DOI
10.1111/pai.12778
Knihovny.cz E-resources
- MeSH
- Databases, Factual MeSH
- Child MeSH
- Herbal Medicine statistics & numerical data MeSH
- Infant MeSH
- Drug Hypersensitivity epidemiology MeSH
- Humans MeSH
- Adolescent MeSH
- Drug-Related Side Effects and Adverse Reactions epidemiology MeSH
- Child, Preschool MeSH
- Retrospective Studies MeSH
- Check Tag
- Child MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
BACKGROUND: The use of herbal medicines in children and the general population is continually on the rise with an overall herbal lifetime and current use ranging between 0.8%-85.5% and 2.2%-8.9%, respectively. Although acute hypersensitivity reactions are generally considered to be rare, little knowledge exists on the frequency and type of these reactions especially in specific populations like children. OBJECTIVES: To assess the patterns of acute hypersensitivity reactions to herbal medicines reported to the WHO global individual case safety report (ICSR) database VigiBase® in children. STUDY DESIGN: From the original VigiBase® extract for the time between 1968 and 2014, we included all reports with adverse drug reactions (ADR) associated with herbal medicines in children where WHO-ART reaction terms were indicative of acute hypersensitivity reactions. RESULTS: VigiBase® contained 2646 ICSRs with 14 860 distinct adverse reactions reported in association with herbal medicine in children. Among those, 79 cases with 107 allergy-like reactions met our inclusion criteria. The most commonly reported WHO-ART terms were urticaria or rash/rash erythematous (59.8%), and allergic reaction (8.4%). The most frequently reported suspected herbal medicines were mixed herbal products (51.4%), Hedera helix (15.0%), and Echinacea purpurea (5.6%). Most frequent routes of administration were oral (75.9%), topical (8.9%), and rectal (3.8%). Over 30% of cases were reported in the age group from 7 to 12 years. The majority of reports were received from Germany (29.1%), Thailand (21.5%), and Australia (11.4%). CONCLUSION: VigiBase® contains a considerable number of acute hypersensitivity reactions in children associated with herbal medicines, including life-threatening reactions such as anaphylactic shock.
rugsafety ch Küsnacht Switzerland Institute of Pharmaceutical Sciences ETH Zurich Zurich Switzerland
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18024704
- 003
- CZ-PrNML
- 005
- 20180719095213.0
- 007
- ta
- 008
- 180709s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/pai.12778 $2 doi
- 035 __
- $a (PubMed)28846157
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Meincke, Ricarda $u Department of Social and Clinical Pharmacy, Faculty of Pharmacy, Charles University in Prague, Hradec Kralove, Czech Republic.
- 245 10
- $a Allergy-like immediate reactions with herbal medicines in children: A retrospective study using data from VigiBase® / $c R. Meincke, J. Pokladnikova, J. Straznicka, RHB. Meyboom, D. Niedrig, S. Russmann, L. Jahodar,
- 520 9_
- $a BACKGROUND: The use of herbal medicines in children and the general population is continually on the rise with an overall herbal lifetime and current use ranging between 0.8%-85.5% and 2.2%-8.9%, respectively. Although acute hypersensitivity reactions are generally considered to be rare, little knowledge exists on the frequency and type of these reactions especially in specific populations like children. OBJECTIVES: To assess the patterns of acute hypersensitivity reactions to herbal medicines reported to the WHO global individual case safety report (ICSR) database VigiBase® in children. STUDY DESIGN: From the original VigiBase® extract for the time between 1968 and 2014, we included all reports with adverse drug reactions (ADR) associated with herbal medicines in children where WHO-ART reaction terms were indicative of acute hypersensitivity reactions. RESULTS: VigiBase® contained 2646 ICSRs with 14 860 distinct adverse reactions reported in association with herbal medicine in children. Among those, 79 cases with 107 allergy-like reactions met our inclusion criteria. The most commonly reported WHO-ART terms were urticaria or rash/rash erythematous (59.8%), and allergic reaction (8.4%). The most frequently reported suspected herbal medicines were mixed herbal products (51.4%), Hedera helix (15.0%), and Echinacea purpurea (5.6%). Most frequent routes of administration were oral (75.9%), topical (8.9%), and rectal (3.8%). Over 30% of cases were reported in the age group from 7 to 12 years. The majority of reports were received from Germany (29.1%), Thailand (21.5%), and Australia (11.4%). CONCLUSION: VigiBase® contains a considerable number of acute hypersensitivity reactions in children associated with herbal medicines, including life-threatening reactions such as anaphylactic shock.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a databáze faktografické $7 D016208
- 650 _2
- $a léková alergie $x epidemiologie $7 D004342
- 650 _2
- $a nežádoucí účinky léčiv $x epidemiologie $7 D064420
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a herbální medicína $x statistika a číselné údaje $7 D029001
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a retrospektivní studie $7 D012189
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Pokladnikova, Jitka $u Department of Social and Clinical Pharmacy, Faculty of Pharmacy, Charles University in Prague, Hradec Kralove, Czech Republic.
- 700 1_
- $a Straznicka, Julie $u Department of Social and Clinical Pharmacy, Faculty of Pharmacy, Charles University in Prague, Hradec Kralove, Czech Republic.
- 700 1_
- $a Meyboom, Ronald H B $u WHO Collaborating Centre for International Drug Monitoring, Uppsala Monitoring Centre, Uppsala, Sweden. Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht University, Utrecht, The Netherlands.
- 700 1_
- $a Niedrig, David $u University Children's Hospital Zurich, Zurich, Switzerland.
- 700 1_
- $a Russmann, Stefan $u drugsafety.ch, Küsnacht, Switzerland. Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.
- 700 1_
- $a Jahodar, Ludek $u Department of Pharmaceutical Botany and Ecology, Faculty of Pharmacy, Charles University in Prague, Hradec Kralove, Czech Republic.
- 773 0_
- $w MED00010395 $t Pediatric allergy and immunology official publication of the European Society of Pediatric Allergy and Immunology $x 1399-3038 $g Roč. 28, č. 7 (2017), s. 668-674
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28846157 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20180719095514 $b ABA008
- 999 __
- $a ok $b bmc $g 1316835 $s 1021625
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 28 $c 7 $d 668-674 $e 20171003 $i 1399-3038 $m Pediatric allergy and immunology $n Pediatr Allergy Immunol $x MED00010395
- LZP __
- $a Pubmed-20180709
